Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Spectrum Pharmaceuticals Q3 EPS $(0.12) Beats $(0.15) Estimate

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share
byBenzinga Newsdesk
November 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

‘Apple Slashes Prices Of iPhone 15 Models To New Low In China Amid Heated Competition In World’s Largest Smartphone Market; Mainland Online Retailers JD.com And Alibaba’s Tmall On Monday Started Offering Deeper Discounts On iPhone 15 Models’ – SCMP

By Benzinga Newsdesk
May 20, 8:51 AM
https://www.scmp.com/tech/big-tech/article/3263357/apple-slashes-prices-iphone-15-models-new-low-china-amid-heated-competition-worlds-largest Apple is offering a new range of steep discounts for iPhone 15 models to

AAPL